Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase III results reported for apaziquone

April 10, 2012

Novel anticancer nanomedicine shows promise in clinical trial

April 10, 2012

Amgen presents first preclinical data on novel anticancer drug

April 10, 2012

ARMOR1 trial assesses safety of galeterone in prostate cancer

April 10, 2012

New protein kinase inhibitors disclosed by Bayer Schering Pharma

April 10, 2012

FDA grants priority review to Zaltrap BLA

April 5, 2012

Trillium provides update on lead cancer program

April 5, 2012

Novel BTK inhibitors reported

April 5, 2012

GTx replies to FDA's clinical hold letter regarding Capesaris

April 5, 2012

University of Pittsburgh synthesizes new p53/Mdm2 antagonists

April 5, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...